Browse by Section 100 Item List

Highly Specialised Drugs Program (Private Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the PBS.

The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:

  • 10% for drugs with an ex-manufacturer price of less than $40
  • $4 for drugs with an ex-manufacturer price of between $40 and $100
  • 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
  • $40 for drugs with an ex-manufacturer price of greater than $1000.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 6423C LANREOTIDElanreotide 60 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 6424D LANREOTIDElanreotide 90 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 11527Q LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 6425E LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 9635D LANTHANUMlanthanum 500 mg chewable tablet, 2 x 45 2 180 5
MP 9636E LANTHANUMlanthanum 750 mg chewable tablet, 6 x 15 2 180 5
MP 9637F LANTHANUMlanthanum 1 g chewable tablet, 6 x 15 2 180 5
MP 11966T LENALIDOMIDElenalidomide 5 mg capsule, 28 1 28 2
MP 11969Y LENALIDOMIDElenalidomide 10 mg capsule, 28 1 28 2
MP 14615F LENALIDOMIDElenalidomide 20 mg capsule, 14 1 14 3
MP 11965R LENALIDOMIDElenalidomide 15 mg capsule, 28 1 28 2
MP 11063G LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 0
MP 12050F LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 1
MP 12060R LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 3
MP 12980E LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 2
MP 13658W LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 2
MP 2796E LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 3
MP 9643M LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 0
MP 11042E LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 0
MP 12011E LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 1
MP 12020P LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 3
MP 12986L LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 2
MP 13657T LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 2
MP 9644N LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 0
MP 11055W LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 0
MP 12037M LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 1
MP 12068E LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 3
MP 12993W LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 2
MP 13660Y LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 2
MP 9645P LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 0
MP 11036W LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 0
MP 12038N LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 1
MP 12071H LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 3
MP 12984J LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 2
MP 13642B LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 2
MP 2798G LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 3
MP 9642L LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 0
MP 12004T LENALIDOMIDElenalidomide 10 mg capsule, 14 1 14 3
MP 12069F LENALIDOMIDElenalidomide 15 mg capsule, 14 1 14 3
MP 12018M LENALIDOMIDElenalidomide 25 mg capsule, 14 1 14 3
MP 14582L LENALIDOMIDElenalidomide 20 mg capsule, 21 1 21 2
MP 14583M LENALIDOMIDElenalidomide 20 mg capsule, 21 1 21 2
MP 14609X LENALIDOMIDElenalidomide 20 mg capsule, 21 1 21 1
MP 14610Y LENALIDOMIDElenalidomide 20 mg capsule, 21 1 21 0
MP 14624Q LENALIDOMIDElenalidomide 20 mg capsule, 21 1 21 0
MP 14631C LENALIDOMIDElenalidomide 20 mg capsule, 21 1 21 3
MP 12058P LENALIDOMIDElenalidomide 5 mg capsule, 14 1 14 3
MP 11910W LEVODOPA + CARBIDOPAlevodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL 4 28 5
MP 9744W LEVODOPA + CARBIDOPAlevodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL 8 56 5
MP 10931H LIPEGFILGRASTIMlipegfilgrastim 6 mg/0.6 mL injection, 0.6 mL syringe 1 1 11
MP 13795C LUMACAFTOR + IVACAFTORlumacaftor 75 mg + ivacaftor 94 mg granules, 56 sachets 1 56 5
MP 11463H LUMACAFTOR + IVACAFTORlumacaftor 200 mg + ivacaftor 125 mg tablet, 112 1 112 5
MP 11464J LUMACAFTOR + IVACAFTORlumacaftor 100 mg + ivacaftor 125 mg tablet, 112 1 112 5
MP 11841F LUMACAFTOR + IVACAFTORlumacaftor 100 mg + ivacaftor 125 mg granules, 56 sachets 1 56 5
MP 11848N LUMACAFTOR + IVACAFTORlumacaftor 150 mg + ivacaftor 188 mg granules, 56 sachets 1 56 5